Article
Improving the calling of non-invasive prenatal testing on 13-/18-/21-trisomy by support vector machine discrimination
2017-11-09
Abstract excerpt
With the advance of next-generation sequencing technologies, non-invasive prenatal testing (NIPT) has been developed and employed in fetal aneuploidy screening on 13-/18-/21-trisomies through detecting cell-free fetal DNA (cffDNA) in maternal blood. Although Z test is widely used in NIPT nowadays, there is still necessity to improve its accuracy for removing a) false negatives and false positives, and b) the ratio...
Topics
Open a Topic to create a Post that cites this publication.
- Congenital Anomalies and Fetal Surgery
- Fetal and Pediatric Neurological Disorders
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Genomic variations and chromosomal abnormalities
- Pregnancy and preeclampsia studies
- Prenatal Screening and Diagnostics
- Sexual Differentiation and Disorders
Identifiers and source
- Literature Corpus work
- 4448dc3b-2af1-5ba0-98fc-65620973e4c8
- DOI
- 10.1101/216689
